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Abstract.  Phospholipid remodeling resulting  in ara- 
chidonic acid (AA) release and metabolism in human 
neutrophils  stimulated by calcium ionophore A23187 
has been extensively studied, while data obtained 
using physiologically relevant stimuli is limited. 
Opsonized zymosan and immune complexes induced 
stimulus-specific alterations  in lipid metabolism that 
were different from those induced by A23187. [3H]AA 
release correlated with activation of phospholipase A2 
(PLA2) but not with cellular activation as indicated by 
superoxide generation.  The latter correlated more with 
calcium-dependent phospholipase C  (PLC) activation 
and elevation of cellular diacylglycerol (DAG) levels. 
When cells that had been allowed to incorporate 
[3H]AA were stimulated with A23187, large amounts of 
labeled AA was released, most of which was metabo- 
lized to 5-HETE and leukotriene B4.  Stimulation with 
immune complexes also resulted in the release of 
[3H]AA but this released radiolabeled AA was not 
metabolized.  In contrast,  stimulation with opsonized 
zymosan induced no detectable release of [3H]AA. 
Analysis of [3H]AA-labeled lipids in resting cells indi- 
cated that the greatest amount of label was incorpo- 
rated into the phosphatidylinositol  (PI) pool, followed 
closely by phosphatidylcholine and phosphatidylserine, 
while little  [3H]AA was detected in the phos- 
phatidylethanolamine pool. During stimulation with 
A23187, a significant decrease in labeled PI occurred 
and labeled free fatty acid in the pellet increased. 
With immune complexes, only a small decrease was 
seen in labeled PI while the free fatty acid in the 
pellets was unchanged.  In contrast,  opsonized zymosan 
decreased labeled PI,  and increased labeled DAG. 
Phospholipase activity in homogenates from human 
neutrophils  was also assayed. A23187 and immune 
complexes, but not zymosan, significantly enhanced 
PLA2 activity in the cell homogenates.  On the other 
hand,  PLC activity was enhanced by zymosan and im- 
mune complexes. Stimulated increases in PLC activity 
correlated with enhanced superoxide generation in- 
duced by the stimulus. 
T I V A T I O S  of neutrophils is intimately linked to changes 
in phospholipid metabolism (40, 43, 44). Released 
arachidonic  acid (AA)'  from membrane phospho- 
lipids (PLs) provides a substrate for the formation  of bioac- 
tive lipids that can modulate cell responses (4, 33, 34). Addi- 
tionally, nonmetabolized AA has been shown to activate the 
neutrophil  NADPH oxidase (2,  15). It is also possible that 
phospholipid  remodeling  resulting  in  the  release  of AA 
and/or the formation  of lysophospholipids may be a method 
of altering cell membrane fluidity during signal transduction 
(36).  Crucial cell functions (i.e., phagocytosis,  carrier-me- 
diated transport,  membrane-bound enzymes) can be altered 
by fatty acid enrichment  (21, 22, 31, 39). 
1. Abbreviations  used in this paper:  AA, arachidonic acid; DAG, diacyl- 
glycerol;  LTB4, leukotriene  B4;  PC,  phosphatidylcholine; PE,  phospha- 
tidylethanolamine;  PI,  phosphatidylinositol;  PL,  phospholipid;  PLA2, 
phospholipase A:;  PLase,  phospholipase;  PLC,  phospholipase  C;  PS, 
phosphatidylserine. 
The mechanism of AA release, as well as the characteriza- 
tion of the lipid pool from which it originates,  has been ex- 
amined in several cell types (26, 29). Previous investigators 
have demonstrated  enhanced membrane phospholipase A2 
(PLA2) activity in neutrophil  membrane preparations  stim- 
ulated with FMLP (9). AA release via PLA2 was also dem- 
onstrated in calcium ionophore-stimulated cells (40, 43, 44) 
and  suggested  as  a  mechanism  during  activation  by op- 
sonized  zymosan (43, 44).  Release of AA via action of a 
phospholipase C (PLC) in conjunction  with a diglyceride li- 
pase (28),  or by a combination of PLC-diglyceride kinase- 
PLA2, has also been suggested as possible mechanisms for 
AA release (5). Experiments  by Takenawa et al. (40) present 
evidence that the latter mechanism is responsible for AA re- 
lease in FMLP-stimulated neutrophils,  while the ionophore 
enhanced  PLA2 exclusively. This  is supported by other in- 
vestigators who show that FMLP stimulates PLC activity in 
neutrophils  (11). Studies with  [3H]AA-labeled  neutrophils 
indicate that phosphatidylinositol  (PI) and phosphatidylcho- 
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bel and that these pools are depleted during stimulation (40, 
43, 44). Alternatively, studies by Okajima and Ui (20) show 
loss of [3H]AA  label  from PC,  phosphatyldethanolamine 
(PE), and PI during FMLP stimulation of radiolabeled gui- 
nea pig neutrophils. The mechanisms of neutrophil AA re- 
lease and the pool from which it is derived is even less well 
established for other physiologic stimuli. 
Conversion of AA by neutrophils primarily results in the 
formation of products via the 5-1ipoxygenase  pathway (8). 
Key products of this pathway are 5-HETE and leukotriene 
Ba (LTB4). These lipid metabolites are potent chemotactic 
and  activation  agents  for  polymorphonuclear  leukocytes 
(35),  as well as regulators of enzyme function (4). Genera- 
tion of substantial amounts of these lipoxygenase products 
has been elicited from neutrophils by A23187 (12, 44).  In 
contrast, the amount of product formed in response to physi- 
ological stimuli is exceedingly small (45). 
Because A23187 is an ionophore, not a physiologic stimu- 
lus, it is possible that data obtained with this are not physio- 
logically relevant and possibly confuse the issue of AA me- 
tabolism. In the present study, we have examined neutrophils 
to further characterize the mechanisms of AA release (using 
[3H]AA)  and determine  from which pool the AA  is  de- 
rived. To do this we used phagocytic stimuli for the study of 
both PL and AA metabolism. 
Materials and Methods 
Superoxide Generation (Oi) from Stimulated 
Human Neutrophils 
Superoxide anion generation was determined by means of the superoxide 
dismutase-inhibitable reduction of cytochrome c as described by Babior et 
al. (1), modified for use in a microelisa reader (model MR600;  Dynatech 
Corp., Alexandria, VA) (18). Reduced cytochrome c was determined using 
an extinction coefficient for reduced-oxidized cytochrome c of 21.1 mM  -~ 
cm  -I (1). 
Protein Determination 
Protein concentration in cell sonicates was determined by the method of 
Bradford (10) utilizing reagents supplied by Bio-Rad Laboratories (Rich- 
mond, CA). BSA (Miles Laboratories, Inc., Naperville, IL) was used as a 
standard. 
Reagents and Chemicals 
All solvents were of HPLC grade and were obtained from Fisher Scientific 
Co.  (Springfield, NJ).  Other chemicals were obtained from the Sigma 
Chemical Co. (St. Louis, MO). Zymosan (Sigma Chemical Co.) was op- 
sonized in 50% human serum for 30 rain at 37°C. Immune precipitates were 
formed by adding excess antigen (CooperBiomedical, Inc., Malvern, PA). 
Radiochemicals were obtained from either New England Nuclear (Boston, 
MA) or Amersham Corp.  (Arlington Heights, IL). 
Isolation and FH]AA Labeling of Human Neutrophils 
Human peripheral blood polymorphonuclear leukocytes were isolated from 
heparinized blood of adult volunteers by Ficoll-Hypaque density gradient 
centrifugation, dextran sedimentation, and hypotonic lysis as previously de- 
scribed (47). Neutrophils were labeled by a modification of the method of 
Lee et al. (24). Briefly, 120-140 million cells were suspended at a concentra- 
tion of 7.5  x  107 cells/m1  in PBS containing 0.1%  fatty acid free BSA 
(Miles Laboratories, Inc.). To this suspension 40-60 I.tCi of [3H]AA (83.3 
Ci/mmole; New England Nuclear) was added and then the cells were in- 
cubated for 60 rain at 37°C. We chose a radiolabel with high specific activity 
to minimize the cellular effects that exogenous AA can elicit (2, 15). After 
the incubation, the cells were washed three times in PBS containing fatty 
acid free BSA (0.01%) and resuspended in PBS. 
Activation of  Neutrophils and Identification of 
AA Metabolites 
Aliquots of 3-4  million  [3H]AA-labeled  cells (7.5-8.0  x  106/ml) were 
placed in tubes containing either calcium ionophore A23187 (final concen- 
tration 10 I~M, for 5 rain), precipitated immune complexes (human serum 
albumin, anti-human serum albumin; 1.5 mg/ml, for 15 rain), or opsonized 
zymosan (1.0 mg/ml, 9  x  107 particles/ml, for 15 min), and incubated at 
37°C. After incubation the cells were sedimented (500 g for 10 rain), spurt 
down, and assayed for the release of radiolabel.  The pellets from these 
studies were saved for radiolabeled lipid analysis. 
A  10-fold greater number of neutrophils (30-40  x  106 at 7.5-8.0  x 
106/ml) was used for the experiments assessing the metabolism of [3H]AA. 
After the designated time period, the cells were pelleted (500 g for 1(3 rain) 
and the supernatants (4-5 ml) extracted using C~s cartridges (SEP-PAK; 
Waters Associates, Milford, MA). The cartridges were eluted with 4 ml of 
methanol and the eluent was then reduced in volume to 200 I~1 under a 
stream  of  nitrogen.  Recovery  of  radiolabel  from  C~8  cartridges  was 
"~90-95 % (data not shown). 
The methanol extracts were chromatographed using a 5-gin Cl8 Nova- 
PAK column (Waters  Associates). A  flow rate of 1.5 ml/min and a two- 
solvent system was used. Solvent I (59:41:0.0004;  water/acetonitrile/phos- 
phoric acid) was run isocratically for 17 min. After a linear gradient of 15 
rain, the next portion was run isocratically for 18 rain to give a final ratio 
of 15 % solvent I and 85 % solvent II (acetonitrile). Absorbance was continu- 
ously monitored at 280 and 234 nm using a variable wavelength detector 
(model 165; Beckman Instruments, Inc., Palo Alto, CA). Absorbance data 
received at 234 ran was linked to an integrator (model C-RIB; Shimadzu 
Scientific Instruments, Inc., Columbia, MD) while that, at 280 nm, was 
processed by the Ramona D radioactivity monitor (INUS, Fairfield, NJ), 
coupled to an Apple IIe computer. 
Analysis of pH]AA-Labeled Cellular Lipids 
Cell pellets from [3H]AA-labeled  cells were extracted with  100  ~tl of a 
chloroform/methanol solution (2:1) and the iipids identified by TLC. 25-~tl 
aliquots of the organic phase were chromatugraphed using Silica Gel G 
(Analtech, Inc., Newark, DE). TLC plates were run using a solvent system 
previously described (23). A solvent system of chloroform/ethanol/triethyl- 
amine/water (30: 34:35:4) was used for the separation of major PL classes, 
while neutral lipids were separated with solvent system of n-heptane/di- 
ethylether/acetic acid (75:25:4).  Lipid standards were added to the sample 
to facilitate visualization by iodine vapors. The bands were marked and, af- 
ter the iodine evaporated, the bands were scaped into vials for scintillation 
counting.  It  is  possible  that  the  bh  [3H]AA  incorporation  was  not 
sufficient to attain equilibrium within the neutrophil phospholipid pools al- 
though there is suggestive evidence to the contrary (40). Since neutrophils 
have a short functional lifespan in vitro, we decided against a longer incor- 
poration time so as not to compromise their ability to respond to the stimuli. 
PhosphoUpase Assays 
Phospholipase (PLase) assays were performed as we have previously de- 
scribed (7,  13). Briefly, phospholipid substmtes were placed in microcen- 
trifuge tubes to which aliquots of cell homogenates were added and the two 
incubated together. PLA2 assays required the use of substrates labeled at 
the polar head group, while the PLC assays utilized lipids labeled in the sn-2 
position with radiolabeled arachidonate. When adding 3H-label in order to 
hgve a final substrate concentration of 10 p,M in the reaction, it was neces- 
sary to add cold lipid (PC, PI, or PE; Sigma Chemical Co.) due to the high 
specific activity of  these compounds. The organic solvent in which the lipids 
are dissolved was evaporated under nitrogen, the residue was then dissolved 
in sodium deoxycholate (5 ~tg/ml, in water) to a final substrate concentration 
of 50 I.tM. Cells were pelleted (5,000 g for 2 min), brought up in a solution 
of protease inhibitors (13), and immediately sonicated with 2-s-bursts maxi- 
mum intensity (Branson Sonicator; power setting No.  7;  Branson Sonic 
Power Co., Danbury, CT). 
The final reaction mixture contained 10 I.tl of substrate, 20 lxl of the cell 
sonicate, 10 I.tl 0.1 M Hepes buffer (pH 8.0 for PLC or 0.2 M Tris buffer 
pH 9.0 for PLA2), and 10 txl of a 50 mM NaCI/0.4 mM CaC12 solution for 
a final PL concentration of 10 gM. The reaction mixture was begun by the 
addition of the sonicate and incubated for 1 h at 37°C, and then stopped by 
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then 50 p.l of 4  M  KCi. The mixture was then centrifuged at 5,000 g  for 
1 min to separate the aqueous phase from the organic phase.  ~  20 
50-1xl aliquots of the organic layer were spotted on Silica Gel G plates 
(Analtech, Inc.) and chromatographed in either solvent system A (chloro-  E 
form/methanol/acetic acid/water; 50:30:8:4) to separate the lysophospho-  ~  io 
lipids from the phospholipids or solvent system B (petroleum ether/diethyl  ~" 
ether/acetic acid; 70:30:1) to separate the neutral lipids from the phospholip- 
ids.  PLA2 activity  was  determined  (solvent A)  by  quantification of the 
amount of lysophospholipid produced and PLC activity was quantified by 





Release of Radiolabel from rH]AA-Labeled 
Neutrophils 
0 
Aliquots of neutrophils labeled with tritiated AA were stimu- 
lated with either calcium ionophore A23187, precipitated im- 
mune complexes, or opsonized zymosan, and the appearance  B 
of radioactivity in the supernatant was measured at various 
time intervals  up to 45  min (Fig.  1).  [3H]AA-labeled neu- 
trophils  challenged  with  ionophore  released  15.7  +  0.5%  ~  i.o 
(mean  +  SEM)  of incorporated  radiolabel  (91%  of maxi-  [ 
mum release) within 10 min. Little or no additional [3H]AA  ~ a, 
was released over the next 35 min. Immune complex stimula- 
tion  of labeled  neutrophils  also  elicited  [3H]AA  release, 
however,  unlike  the  ionophore,  a  gradual  response  was 
1.6 
noted. Over the course of the experiment, 6.5  -t- 1.3 % of the 
incorporated counts were released but the release was still  o  1.0 
continuing at 45 min. In marked contrast, opsonized zymo- 
san promoted no significant release of radiolabel. Additional 
O4 
experiments  using  ionophore-treated  cells were performed 
with fatty acid free BSA in the media to facilitate "trapping" 
and decrease reacylation of released radiolipids.  The results 
(expressed in  %3H released) indicated no significant differ- 
c  ence between experiments with BSA (11.8 +  3.9, n  =  4) or 
those without BSA (11.9  +  4.3,  n  =  8). 
Metabolism  of pH]AA from Labeled Neutrophils 
Differences between activation by physiologic stimuli or the 
calcium ionophore were not only apparent in the magnitude 
of [3H]AA release, but extended to [3H]AA metabolism as 
well.  Stimulation of [3H]AA-labeled neutrophils with iono- 
phore resulted in conversion of most of the released radio- 
label into 5-1ipoxygenase products (Fig. 2). Conversion was 
primarily  to  radiolabeled  5-HETE  and  LTB4  (along  with 
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bTgure 1. Time course of [3H]- 
AA release by stimulated hu- 
man neutrophils.  Neutrophils 
labeled with [3H]AA were ex- 
posed to either calcium iono- 
phore  A23187 (10  p.M),  pre- 
cipitated  immune  complexes 
(1.5 mg/ml), opsonized zymo- 
san (1.0 mg/ml), or PBS. Sam- 
pies of each supernatant were 
collected  for liquid  scintilla- 
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counts expressed as a percentage of the total counts incorporated. 
Results are expressed as the mean and SD of two experiments, with 
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Figure 2.  Reverse phase  HPLC  of supernatants  from polymor- 
phonuclear leukocytes activated by ionophore (A),  immune com- 
plexes (B), or opsonized zymosan (C). Each chromatogram illus- 
trates metabolite release by either UV absorbance at 280 nm (top) 
or by monitoring radiolabel (bottom). Retention times of synthetic 
reference standards are indicated by the arrows.  Each chromato- 
gram is representative of three experiments. 
label was 13  Jr 7% in AA, 27  Jr 5% in 5-HETE, and 43  -t- 
18%  in LTB4 (mean  +  SD, n  =  3).  The distribution  of ra- 
diolabel indicated that the method of incorporation used la- 
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Total radiolabeled lipids* 
Control  A23187  Opsonized zymosan  Immune complexes 
%  %  %  % 
Triacylglycerol  22.0  +  1.6  26.2  +  2.2  24.1  +  1.9  24.0  +  1.8 
DAG  2.3  +  0.2  -*  4.7  +  0.5§  3.0  +  0.3 
Monoacylglycerol  0.4 -1- 0.1  -*  0.3 + 0.1  0.4 + 0.1 
Free fatty acid  1.2 5- 0.3  6.9 5-  1.6§  2.5 + 0.7  2.0 5- 0.3 
PE  3.0 + 0.5  3.1  5- 0.7  2.5 5- 0.6  3.4 5- 0.8 
PI  58.1  5- 5.3  34.3 + 6.7§  46.1  5- 6.7§  47.4 5- 6.9§ 
PS  11.3 + 4.0  14.2 5- 4.3  8.0 5- 1.4  9.4 5- 2.5 
PC  11.2 5- 1.8  9.0 5- 1.2  13.3 5-  1.1  10.2 +  1.2 
* Cells were treated with A23187 (I0 gM, 5 min), immune complexes (1.5 
mean +  SEM of 4-5 donors. Each assay performed in triplicate. 
~: Interference by pH]AA metabolites (8.9  +  1.3%). 
§ P  vs. control <0.05, one-tailed test. 
mg/ml 15 min), or opsonized zymosan (1.0 mg/ml, 15 min). Results expressed as 
beled a  pool that was  readily available  for hydrolysis by 
PLase and subsequent metabolism by 5-1ipoxygenase. 
Activation of [3H]AA-labeled neutrophils by physiologic 
stimuli presented a different pattern from that of ionophore- 
treated  cells.  Immune  complex-stimulated  cells  released 
[3H]AA, however the released [aH]AA was not metabolized 
to  any significant extent.  The sensitivity of the detection 
method was such that metabolism of 0.004% of the radiola- 
beled AA released by the immune complexes could have been 
detected. Since opsonized zymosan failed to release [3H]AA 
there was, therefore, no metabolism. Small peaks detected 
by absorbance at 280 nm were seen in both immune complex 
and zymosan-stimulated cells that chromatograph  just before 
LTB4.  It is  possible  that these  represent an  isomer(s)  of 
LTB4. 
Distribution of pH]AA in Cellular Lipids after 
Stimulation of  Human Neutrophils 
To determine the source of the released [3H]AA, the cell 
pellets were assayed for labeled PLs and neutral lipids after 
[3H]AA incorporation and stimulation (Table I). Incorpora- 
tion of [3H]AA  into neutrophil PLs was primarily into PI 
with lesser amounts in PC and phosphatidylserine (PS). This 
is consistent with other investigators who have shown that 
these pools are preferentially labeled with AA (40, 43, 44). 
Our high percentage of radiolabeled PI may be due to the 
short incorporation time, perhaps favoring the more meta- 
bolically active pool as has been previously suggested (32, 
46).  Upon activation with all three stimuli,  label was de- 
creased in the PI pool (Table I), but the decrease was greatest 
in ionophore-stimulated cells. 
Of the neutral lipids, triglycerides contained the most ra- 
diolabel followed by diacylglycerol. The labeling in the tri- 
glyceride bands increased slightly after stimulation support- 
ing the belief that free AA is not derived from this pool, but 
might enter it by reacylation. Initial TLC studies using radio- 
labeled standards showed that 5-HETE primarily migrated 
with the monoglyceride marker while exhibiting significant 
spillover to the diglyceride band  (data not shown).  HPLC 
analysis  indicated that  only ionophore-stimulated neutro- 
phils produced significant quantities of [3H]5-HETE (Fig. 
2).  Therefore, due  to  interference by  5-HETE  (or  other 
mono-HETES) during A23187 stimulation, measurements of 
labeled monoglycerides and diglycerides could not be per- 
formed. Stimulation with zymosan initiated a small, but sig- 
nificant,  increase in  the  amount of [aH]AA-labeled DAG 
without a concurrent release of AA. Conversely, no signifi- 
cant increases in either of  these lipid products were seen with 
immune complexes as the stimulus.  It must be noted that 
variability among donors and lack of sensitivity of the assay 
did not allow for precise quantitation. Neutrophils from two 
out of four of the donors showed slight increases in pH]AA- 
labeled  DAG  and  [3H]AA,  as  well as  slight decreases in 
[3H]AA-containing  PC  during  immune  complex  stimula- 
tion.  Minimal  loss  of  [3H]AA  from  PC  in  ionophore- 
stimulated cells was  also  seen in the majority of donors. 
However, this was not statistically significant by Student's 
one-tailed t-test (30). 
Phospholipase  Activities in Human Neutrophil 
Homogenates 
Because TLC analysis of [3H]AA-labeled lipids did not give 
unequivocal answers to questions about precursor pools and 
the mechanism of AA release from stimulated human neu- 
trophils, the issue was therefore approached from another 
direction. Sonicates of  resting human neutrophils were tested 
for PLase activity by the formation of labeled lysophospho- 
lipids or DAG from the hydrolysis of defined radiolabeled 
substrates. PC, PI, and PE were utilized to determine if the 
enzymatic activity in the homogenates exhibited a preference 
for a specific substrate. Table II shows that of the three sub- 
strates  tested,  PC  was  most  consistently  hydrolyzed by 
PLA2 of all the donors tested. PLA2 activity, using PE and 
PI as substrates, was minimal. Alternatively, PLC preferen- 
tially hydrolyzed PI, with an activity >15-fold that seen with 
PE or PC. PLC activity was present in cells from all of the 
donors. 
Stimulation of  Phospholipase Activities in 
Human Neutrophils 
Increased PLA2 activity was apparent in whole cell homog- 
enates when neutrophil suspensions were stimulated before 
sonication (Table III). Cells were exposed for 5 min to 10 ~tM 
ionophore, or 15 min to either 1.5 mg/ml precipitated im- 
mune  complexes or  1.0  mg/ml  opsonized zymosan,  and 
phospholipase activity was assayed using PC as a substrate. 
Separate time periods were chosen for each individual stimu- 
lus based on the maximal rate of [3H]AA and/or O~ release 
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Substrate  PLA2  PLC  -~ 
pmol/min/mg  pmol/min/mg  %_ 
x 
PC  3.0  +  0.7  0.6  +  0.2 
PI  0.3  +  0.2  51.0  5-  12.4 
PE  1.1  +  0.8  2.6  +  0.9  o 
* Results expressed as mean  +  SEM of 4-5 donors. 
E 
(Figs. 1 and 3). Therefore, we reasoned that maximal PL ac- 
tivity would be associated with the times chosen. The results 
are expressed as percent activity as compared with the un- 
stimulated  control.  PLA2  activity was  enhanced  by  both 
(A23187),  acting via an influx of extracellular calcium and 
by a  phagocytic, Fc receptor-mediated stimulus  (immune 
complexes).  The increased enzymatic activity induced by 
both  ionophore  or  immune  complexes  were  not  signifi- 
cantly different from each other, suggesting that AA may be 
released by both stimuli in whole cells via PLA2. In con- 
trast,  activation of neutrophils by opsonized zymosan re- 
suited in only a slight enhancement of PLA2 activity. 
The effects of these stimuli on PLC activation were differ- 
ent from those found with PLA2 (Table IV). PLC activity in 
homogenates of stimulated neutrophils was assayed using PI 
and PE as substrates.  Examination of Table IV shows that 
A23187 was unable to stimulate PLC activity to any great ex- 
tent with either substrate. On the other hand, both physio- 
logic stimuli were able to increase PLC activity significantly. 
Superoxide (0?2) Generation from Stimulated 
Human Neutrophils 
To ensure that the stimuli being used were able to activate 
neutrophils, each stimulus was tested for its ability to initiate 
superoxide production from neutrophils. Neutrophils were 
exposed to  ionophore,  opsonized zymosan,  and  immune 
complexes in the same manner as they were in previous tests. 
Fig.  3  shows  that opsonized zymosan and  immune com- 
plexes were the stimuli capable of initiating a substantial su- 
peroxide release. These stimuli elicited significant amounts 
of superoxide from human neutrophils during the first 10 min 
of stimulation that continued to increase over a 40-min time 
period. In contrast, activation by A23187 resulted in fivefold 
less cytochrome c reduction, as compared with opsonized 
zymosan or immune complexes, with levels slightly over 
those of the control (1.3 vs. 0.7 nmol/l(P cells). The stimuli 
that initiated maximal superoxide were those that increased 
PLC activity, suggesting a possible correlation between the 
two. 
Table IlL Stimulation of PZh2 Activity in Human 
Neutrophil Sonicates 
Stimulus*  Activity (control)$ 
% 
None (control)  100 
A23187  250 + 45 
Immune complexes  210 + 20 
Opsonized zymosan  105 +  12 
* Cells stimulated as described in Table I. 
* Results expressed as mean  +  SEM  of 4  donors,  each assay performed in 
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Figure 3.  Time course of Oi release by stimulated human neu- 
trophils. A comparison of the ability of various stimuli to promote 
superoxide anion release. The concentration of the stimuli used is 
described in Table I. Results are expressed as the mean of two ex- 
periments (+SEM), each data point being the mean of  triplicate de- 
terminations. 
Discussion 
The data presented demonstrate that activation of specific 
PLases, as well as 5-1ipoxygenase, in human neutrophils is 
dependent upon the stimulus encountered. This is especially 
important since these enzymes are ultimately responsible for 
the membrane remodeling that accompanies and is probably 
essential for cell activation (42, 46). Our studies link specific 
stimuli to the initiation of these specific enzymatic activities. 
The relationships that we observed among PLase activation 
and cellular function are summarized in Table V. 
[JI'I]AA Release 
[3H]AA  release from cell membranes has often been used 
as a model system for studies of receptor-mediated PLase 
activation,  particularly  PLA2  (43,  44).  To directly relate 
[SH]AA release with PLase activation, we measured these 
functions in  neutrophils activated by a  panel of unrelated 
stimuli.  We  have  shown  that  neutrophils  release  [3H]AA 
when stimulated with either A23187 or immune complexes 
but not when opsonized zymosan, which binds to cells via 
the C3b receptor, is used. Release of labeled AA from neu- 
trophils  correlated with  enhanced  PLA2  activity, as  mea- 
sured in sonicates of stimulated cells but not with enhanced 
PLC activity (see Tables III and IV). Furthermore, activation 
of 5-1ipoxygenase only occurred with A23187 and did not 
correlate with activation of PLA2  and consequent [SH]AA 
release. 
Table IV. Stimulation of  PLC Activity in Human 
Neutrophil Sonicates 
Activity (Control)* 
Stimulus*  PI  PE 
%  % 
Control  100  100 
A23187  97.8  +  6.3  91.0  +  52.7 
Opsonized zymosan  152.3  +  33.6§  331.5  +  162.2 
Immune complexes  135.3  +  29.3§  500.3  +  188.8 
* Cells stimulated as described 
* Results expressed as mean  + 
§ P  vs. control <0.05. 
in Table I. 
SEM,  n  =  4  donors. 
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Superoxide Release 
Stimuli 
Function  A23187  Immune complex  Opsonized zymosan 
PLA2  +  +  - 
[3H]AA release  +  + 
[3H]AA metabolism  +  - 
PLC  -  +  + 
DAG  -  ±  + 
O~  _+  +  + 
PLA  2 Activity 
PLA2 activity can be detected in neutrophil sonicates by the 
use of  defined radiolabeled substrates (7). We used this meth- 
od  to  measure  PLA2  activity after cell  stimulation.  The 
technique was able to detect increases in activity in the stim- 
ulated cells,  however it was  not possible to use it to ac- 
curately measure small differences in activity. The results we 
obtained with this in vitro PLA2 assay correlated with the 
results obtained by observing [3H]AA release, that is activ- 
ity was increased in cells stimulated with ionophore and im- 
mune complexes before sonication but not when zymosan 
was used as a stimulus. The results are consistent with sev- 
eral other studies reporting activation of PLA2 by the iono- 
phore (40, 43, 44). Although there are reports in the litera- 
ture of receptor-mediated PLA2-activation by FMLP (29), 
there are no reports concerning immune complex activation 
of PLA2 in neutrophlls.  However, studies using peritoneal 
macrophages show that in this cell PLA2 enzyme may be 
linked to the Fc2b receptor, thus providing a potential link 
between  immune  complex  stimulation  and  PLA2 action 
(27, 38). 
PLC Activity 
We also examined PLC activity in the same fashion. Studies 
of PLC activity in inflammatory cells have centered around 
the inositol response with particular attention to the inositol 
phosphates as second messengers (3). For example, FMLP- 
stimulated neutrophils show increases in the inositol phos- 
phates, particularly IP3, during the first 10 s post-stimula- 
tion (41).  We demonstrated enhanced PLC activity vs.  PI 
with the neutrophil sonicates upon prior stimulation with im- 
mune complexes and opsonized zymosan.  This technique 
utilizes PI as a substrate and the enzyme activity has been 
shown  to  be  calcium dependent  (7).  Calcium-dependent 
PLC activity towards PI has also been seen in preparations 
of ram seminal vesicles (19) and in FMLP-stimulated guinea 
pig neutrophils (25), and is characterized by its extended re- 
sponse upon activation. We also observed enhanced activity 
using PE as a substrate, although this activity was one-tenth 
that obtained when using PI as the substrate. However, the 
concentration of PE in the cell is much greater than PI, and 
this small activity may be enough to provide the appropriate 
lipid  molecules  (i.e.,  DAG)  from sources other  than  PI. 
Ionophore stimulation by itself was unable to increase PLC 
activity, thus supporting data presented by a number of inves- 
tigators (40, 44). Since the activity that we observed is cal- 
cium dependent, it is possible that additional signals are re- 
quired for PLC activation. 
Distribution of Cellular pH]AA 
We also examined the changes in distribution of pH]AA la- 
bel in neutrophils exposed to these same stimuli.  Analysis 
of [3H]AA-labeled cellular lipids  was  performed at  time 
points that correlated with the maximal rate of [3H]AA re- 
lease. The technique used for labeling cells primarily labeled 
PI and to a lesser extent PC and PS, however the only sig- 
nificant loss of radiolabel during stimulation came from PI. 
Treatment with ionophore depleted this pool considerably. 
This probably occurred via PLA2 since the ionophore has 
not been shown to activate a neutrophil PLC, but has been 
shown to induce a PLA2 capable of using PI as a substrate 
(40). The decreases in PI were not as marked when opson- 
ized zymosan or immune complexes were used as the stimu- 
lus (Table I). 
The most likely explanation for the fact that the PI pool 
appears to be the only pool affected may be linked to the 
method of incorporation. The fatty acid carrier and duration 
of labeling play a large role in determining which PLS con- 
tain  radiolabel  (40,  44).  In  the present  study,  substantial 
amounts of [3H]AA  were in a highly active, cellular pool 
(PI) (32, 46), while low-turnover pools of high cellular con- 
centration (i.e., PC) contained much less. Therefore, a small 
or moderate increase in PLA2 activity using the PC pooi 
may not appear to release significant amounts due to the very 
low specific activity within the labeled PC pool.  Alterna- 
tively, liberation of [3H]AA  by immune complex stimula- 
tion may occur by the pathway of PLC coupled with a DAG 
kinase and a PLA2 acting on phosphatidic acid as seen by 
Takenawa et al.  (40). Examination of [3H]AA-labeled neu- 
tral lipids shows that significant changes were observed dur- 
ing zymosan activation. Stimulation with opsonized zymo- 
san resulted in increased levels of PH]AA-DAG.  Immune 
complex stimulation resulted in no significant increases in la- 
beled AA in cell pellets, nor was the labeled DAG increase 
as prominent as in the zymosan-treated cells. FMLP stimula- 
tion of rabbit neutrophils has been shown to generate an in- 
crease in [3H]AA-DAG production, the maximum level oc- 
curring at 30 s followed by a steep decline (42). In the present 
study, cellular lipids were extracted and analyzed at times 
corresponding to the maximal rate of pH]AA and/or 02- 
release (Figs. 1 and 3). At this time it is not clear what mech- 
anism  is  responsible  for  the  [3H]AA-DAG  accumulation 
during zymosan stimulation. Due to the transient existence 
of [3H]AA-DAG formed by the breakdown of the polyphos- 
phoinositides,  it is unlikely that the majority of [3H]AA- 
DAG is derived from this source during zymosan stimula- 
tion. The most probable explanation is that the labeled DAG 
is generated via a calcium-dependent PLC-activated down- 
stream of an initial PLC-polyphosphoinositide event. 
pH]AA Metabolism 
Previous investigators have suggested that the rate limiting 
step in 5-1ipoxygenase activity is the release of AA (44). In 
contrast, the results we report would suggest that 5-1ipoxyge- 
nase must be  separately  activated.  Challenge of pH]AA- 
labeled neutrophils with ionophore resulted in the metabo- 
lism  of [3H]-AA  primarily  into  5-1ipoxygenase products. 
These results are similar to those obtained by a number of 
investigators examining ionophore-activated neutrophils and 
confirm that this method of labeling neutrophils labels a pool 
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Surprisingly, in the case of activation by the immune com- 
plexes,  released AA is not metabolized. 
The separation of stimulus-induced PLA2 activity from 
5-1ipoxygenase  action has been demonstrated in both neu- 
trophils (12) and macrophages (20).  Clancy et al. (12) have 
shown that FMLP- and C5a-stimulated neutrophils could 
only produce 5-HETE and LTB4 when exogenous AA was 
added, suggesting that 5-1ipoxygenase but not PLA2 was ac- 
tivated. In contrast to the results obtained by these investiga- 
tors with FMLP, stimulation of [3H]AA-labeled  neutrophils 
with immune complexes resulted in activation of PLA2 and 
release of [3H]AA but not its metabolism via 5-1ipoxyge- 
nase. It is obvious from the data we present that not all stim- 
uli induce release of [3H]AA and that conversion of AA to 
5-1ipoxygenase  metabolites by activated cells is  not auto- 
matic. An explanation for this phenomenon is that conditions 
used for  [3H]AA  incorporation may not label  the proper 
phospholipid  pool  from which the  AA  is  released.  This 
possibility has been proposed for other cell types that metab- 
olize AA (20).  However,  the fact that ionophore-stimulated 
cells metabolize the labeled precursor indicates that the la- 
beled pool is susceptible to 5-1ipoxygenase  action. More- 
over, it is improbable that unlabeled AA released by immune 
complex  stimulation would be  preferentially metabolized 
over that of the labeled precursor. On the other hand, studies 
have shown that 5-1ipoxygenase products can be reacylated 
by ionophore-stimulated neutrophils (37). It is possible that 
immune complexes or zymosan activate 5-1ipoxygenase but 
the products are reacylated rapidly. 
Evidence in the literature for physiologic stimuli initiating 
synthesis of 5-1ipoxygenase products is contradictory (6, 12). 
The  most effective  method of stimulating 5-1ipoxygenase 
product formation is by using a calcium ionophore, whereby 
extracellular calcium is allowed into the cell. This stimulus 
strongly activates both PLAz and 5-1ipoxygenase.  It is in- 
teresting to note that unregulated influxes of calcium are a 
characteristic of dying or damaged cells (16). A mechanism 
of release such as this would fit the proinflammatory nature 
of these mediators as well as the suicidal nature of the neu- 
trophil itself. 
Superoxide  (Oiz) vs.  PLase Activity 
Those stimuli that gave  the best superoxide response were 
those that enhanced PLC activity (DAG formation), but not 
PLA2  activity  (AA  release).  It  is  interesting  to  note  that 
these  products  have  been  shown to directly  activate  neu- 
trophil NADPH oxidase in whole cells and cell fractions (2, 
14,  15,  17, 41).  If these lipids are involved in mediating the 
superoxide  response,  then  stimuli  initiating  a  strong  re- 
sponse may be characterized by the ability to form DAG via 
PLC activation. 
Received  for publication 5 May  1986, and in revised form 26 August 1986. 
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